Purchases and Sales Made in Q1 2023 in Nurix Therapeutics, Inc. (NRIX)
This table provides information about the institutional ownership of Nurix Therapeutics, Inc. (NRIX) during Q1 2023. The information is specifically focused on institutions that hold shares of Nurix Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 12, 2023
Q1 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-90.3K- 12.52% |
$773K - $1.2M
|
631K
$13.8M
|
|
|
May 15, 2023
Q1 2023
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-127K- 77.72% |
$1.08M - $1.68M
|
36.3K
$791K
|
|
|
May 15, 2023
Q1 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-148K- 36.84% |
$1.26M - $1.96M
|
253K
$5.51M
|
|
|
May 15, 2023
Q1 2023
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-251K- 8.38% |
$2.15M - $3.33M
|
2.75M
$59.9M
|
|
|
May 15, 2023
Q1 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-273K- 10.87% |
$2.33M - $3.62M
|
2.24M
$48.7M
|
|
|
May 15, 2023
Q1 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-669K- 20.56% |
$5.73M - $8.87M
|
2.58M
$56.3M
|